Sarpietro MG et al. |
Conjugation of squalene to acyclovir improves the affinity for biomembrane models. |
2009 |
Int J Pharm |
pmid:19686827
|
Pellegrini M et al. |
MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. |
2009 |
Vaccine |
pmid:19751689
|
Ryu A et al. |
Squalene as a target molecule in skin hyperpigmentation caused by singlet oxygen. |
2009 |
Biol. Pharm. Bull. |
pmid:19721223
|
Clark TW et al. |
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. |
2009 |
N. Engl. J. Med. |
pmid:19745215
|
Ghimire GP et al. |
Improved squalene production via modulation of the methylerythritol 4-phosphate pathway and heterologous expression of genes from Streptomyces peucetius ATCC 27952 in Escherichia coli. |
2009 |
Appl. Environ. Microbiol. |
pmid:19767465
|
Shabtay A et al. |
The potential of Pleurotus-treated olive mill solid waste as cattle feed. |
2009 |
Bioresour. Technol. |
pmid:19683915
|
Pedroso N et al. |
Modulation of plasma membrane lipid profile and microdomains by H2O2 in Saccharomyces cerevisiae. |
2009 |
Free Radic. Biol. Med. |
pmid:19027845
|
Laitinen K et al. |
Plant stanol ester spreads as components of a balanced diet for pregnant and breast-feeding women: evaluation of clinical safety. |
2009 |
Br. J. Nutr. |
pmid:19017423
|
Pass RF |
Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant. |
2009 |
J. Clin. Virol. |
pmid:19647480
|
Forrest HL et al. |
Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets. |
2009 |
Vaccine |
pmid:19406182
|
López P and MartÃn J |
Potential chemosignals associated with male identity in the amphisbaenian Blanus cinereus. |
2009 |
Chem. Senses |
pmid:19406874
|
Al-Edresi S and Baie S |
Formulation and stability of whitening VCO-in-water nano-cream. |
2009 |
Int J Pharm |
pmid:19429303
|
Camilloni B et al. |
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. |
2009 |
Vaccine |
pmid:19410623
|
Galli G et al. |
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. |
2009 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:19416838
|
Phillips CJ et al. |
Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness. |
2009 |
Vaccine |
pmid:19379786
|
Del Giudice G et al. |
Seasonal influenza vaccine provides priming for A/H1N1 immunization. |
2009 |
Sci Transl Med |
pmid:20371459
|
Seiki S and Frishman WH |
Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia. |
2009 Mar-Apr |
Cardiol Rev |
pmid:19367148
|
Huang MH et al. |
Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine. |
2009 May-Jun |
Microbes Infect. |
pmid:19344782
|
Kopena R et al. |
Lipophilic compounds from the femoral gland secretions of male Hungarian green lizards, Lacerta viridis. |
2009 May-Jun |
Z. Naturforsch., C, J. Biosci. |
pmid:19678551
|
Reddy LH et al. |
Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor. |
2009 Sep-Oct |
Mol. Pharm. |
pmid:19634915
|
Bhilwade HN et al. |
Squalene as novel food factor. |
2010 |
Curr Pharm Biotechnol |
pmid:20874681
|
Iannitti T and Palmieri B |
An update on the therapeutic role of alkylglycerols. |
2010 |
Mar Drugs |
pmid:20948908
|
Smentek L and Hess BA |
Compelling computational evidence for the concerted cyclization of the ABC rings of hopene from protonated squalene. |
2010 |
J. Am. Chem. Soc. |
pmid:21080653
|
Fragapane E et al. |
A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly. |
2010 |
Clin. Vaccine Immunol. |
pmid:20810680
|
Esposito S et al. |
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major. |
2010 |
Vaccine |
pmid:20888873
|
Voyron S et al. |
Antifungal activity of bis-azasqualenes, inhibitors of oxidosqualene cyclase. |
2010 |
Mycoses |
pmid:19549106
|
Khurana S et al. |
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. |
2010 |
Sci Transl Med |
pmid:20371470
|
Lippi G et al. |
Vaccination, squalene and anti-squalene antibodies: facts or fiction? |
2010 |
Eur. J. Intern. Med. |
pmid:20206873
|
Barnett SW et al. |
Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant. |
2010 |
J. Virol. |
pmid:20392857
|
Caron J et al. |
Squalenoyl nucleoside monophosphate nanoassemblies: new prodrug strategy for the delivery of nucleotide analogues. |
2010 |
Bioorg. Med. Chem. Lett. |
pmid:20363623
|
Xiong Z et al. |
A short total synthesis of (+)-omaezakianol via an epoxide-initiated cationic cascade reaction. |
2010 |
Org. Lett. |
pmid:20218639
|
Durando P et al. |
MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk. |
2010 |
Expert Opin Biol Ther |
pmid:20218923
|
Taramino S et al. |
Interactions of oxidosqualene cyclase (Erg7p) with 3-keto reductase (Erg27p) and other enzymes of sterol biosynthesis in yeast. |
2010 |
Biochim. Biophys. Acta |
pmid:19879375
|
van Himbergen TM et al. |
Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway. |
2010 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19834104
|
Keitel W et al. |
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial. |
2010 |
Vaccine |
pmid:19835829
|
Brunner R et al. |
The ABC of clinical and experimental adjuvants--a brief overview. |
2010 |
Immunol. Lett. |
pmid:19895847
|
Eroglu E and Melis A |
Extracellular terpenoid hydrocarbon extraction and quantitation from the green microalgae Botryococcus braunii var. Showa. |
2010 |
Bioresour. Technol. |
pmid:20005092
|
Kalvodova L |
Squalene-based oil-in-water emulsion adjuvants perturb metabolism of neutral lipids and enhance lipid droplet formation. |
2010 |
Biochem. Biophys. Res. Commun. |
pmid:20018176
|
Kimura M et al. |
Protostadienol synthase from Aspergillus fumigatus: functional conversion into lanosterol synthase. |
2010 |
Biochem. Biophys. Res. Commun. |
pmid:19951700
|
Ansaldi F et al. |
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates. |
2010 |
Vaccine |
pmid:20433807
|
Pili B et al. |
Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study. |
2010 |
Biochim. Biophys. Acta |
pmid:20435013
|
Gylling H et al. |
Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study. |
2010 |
J. Lipid Res. |
pmid:20436182
|
Chen G et al. |
Optimization of nitrogen source for enhanced production of squalene from thraustochytrid Aurantiochytrium sp. |
2010 |
N Biotechnol |
pmid:20412873
|
Xiao L et al. |
The effect of squalane-dissolved fullerene-C60 on adipogenesis-accompanied oxidative stress and macrophage activation in a preadipocyte-monocyte co-culture system. |
2010 |
Biomaterials |
pmid:20488530
|
Carmona A et al. |
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. |
2010 |
Vaccine |
pmid:20600478
|
Caligiani A et al. |
Characterization of a potential nutraceutical ingredient: pomegranate (Punica granatum L.) seed oil unsaponifiable fraction. |
2010 |
Plant Foods Hum Nutr |
pmid:20607413
|
Zhao RY et al. |
Cloning and characterization of squalene synthase gene from Fusarium fujikuroi (Saw.) Wr. |
2010 |
J. Ind. Microbiol. Biotechnol. |
pmid:20585832
|
Yasuda Y et al. |
Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children. |
2010 |
Adv Ther |
pmid:20586002
|
Frey SE et al. |
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. |
2010 |
Vaccine |
pmid:20619382
|
Dosio F et al. |
Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation. |
2010 |
Bioconjug. Chem. |
pmid:20597546
|
Sarpietro MG et al. |
Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface. |
2010 |
Int J Pharm |
pmid:20635474
|
Wohlrab J et al. |
Interaction of epicutaneously applied lipids with stratum corneum depends on the presence of either emulsifiers or hydrogenated phosphatidylcholine. |
2010 |
Skin Pharmacol Physiol |
pmid:20523109
|
Koohang A et al. |
Enantioselective inhibition of squalene synthase by aziridine analogues of presqualene diphosphate. |
2010 |
J. Org. Chem. |
pmid:20545375
|
Camin F et al. |
Stable isotope ratios of carbon and hydrogen to distinguish olive oil from shark squalene-squalane. |
2010 |
Rapid Commun. Mass Spectrom. |
pmid:20499327
|
Mantzouridou F and Tsimidou MZ |
Observations on squalene accumulation in Saccharomyces cerevisiae due to the manipulation of HMG2 and ERG6. |
2010 |
FEMS Yeast Res. |
pmid:20550581
|
Van Damme P et al. |
Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. |
2010 |
BMC Infect. Dis. |
pmid:20504306
|
Waddington CS et al. |
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. |
2010 |
BMJ |
pmid:20508026
|
Beck F et al. |
Queries about vaccines containing squalene. |
2010 |
Immunol. Cell Biol. |
pmid:20157330
|
Gerpe A et al. |
Naftifine-analogues as anti-Trypanosoma cruzi agents. |
2010 |
Eur J Med Chem |
pmid:20163894
|
Warleta F et al. |
Squalene protects against oxidative DNA damage in MCF10A human mammary epithelial cells but not in MCF7 and MDA-MB-231 human breast cancer cells. |
2010 |
Food Chem. Toxicol. |
pmid:20138105
|
Sugihara N et al. |
Novel fractionation method for squalene and phytosterols contained in the deodorization distillate of rice bran oil. |
2010 |
J Oleo Sci |
pmid:20103978
|
Chen CC et al. |
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. |
2010 |
Eur J Pharm Biopharm |
pmid:20060469
|
Spanova M et al. |
Effect of lipid particle biogenesis on the subcellular distribution of squalene in the yeast Saccharomyces cerevisiae. |
2010 |
J. Biol. Chem. |
pmid:20032462
|
Tsai T et al. |
Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis. |
2010 |
Vaccine |
pmid:19969117
|
Pietrella D et al. |
A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. |
2010 |
Vaccine |
pmid:20038431
|
Gasparini R et al. |
Impact of prior or concomitant seasonal influenza vaccination on MF59-adjuvanted H1N1v vaccine (Focetria) in adult and elderly subjects. |
2010 |
Int. J. Clin. Pract. |
pmid:20039974
|
De Luca C and Valacchi G |
Surface lipids as multifunctional mediators of skin responses to environmental stimuli. |
2010 |
Mediators Inflamm. |
pmid:20981292
|
Tsuchiya M et al. |
Cholesterol biosynthesis pathway intermediates and inhibitors regulate glucose-stimulated insulin secretion and secretory granule formation in pancreatic beta-cells. |
2010 |
Endocrinology |
pmid:20685866
|
Camilloni B et al. |
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. |
2010 |
Vaccine |
pmid:20846530
|
Ihara T |
[Evaluation of alum-adjuvanted whole virus influenza vaccine and future aspects of influenza A (H1N1) 2009 vaccine]. |
2010 |
Uirusu |
pmid:20848866
|
Sere YY et al. |
A Saccharomyces cerevisiae strain unable to store neutral lipids is tolerant to oxidative stress induced by α-synuclein. |
2010 |
Free Radic. Biol. Med. |
pmid:20850523
|
Narayan BH et al. |
Modulation of doxorubicin-induced genotoxicity by squalene in Balb/c mice. |
2010 |
Food Funct |
pmid:21776469
|
Bildstein L et al. |
Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway. |
2010 |
J Control Release |
pmid:20691740
|
Weiss TL et al. |
Raman spectroscopy analysis of botryococcene hydrocarbons from the green microalga Botryococcus braunii. |
2010 |
J. Biol. Chem. |
pmid:20705610
|
Nakagawa K et al. |
gamma-Tocotrienol reduces squalene hydroperoxide-induced inflammatory responses in HaCaT keratinocytes. |
2010 |
Lipids |
pmid:20714817
|
Black S et al. |
Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: an integrated analysis. |
2010 |
Vaccine |
pmid:20813217
|
Vesikari T et al. |
Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence. |
2010 |
Pediatrics |
pmid:20819892
|
Pili B et al. |
Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation. |
2010 |
Nanoscale |
pmid:20820745
|
Camera E et al. |
Comprehensive analysis of the major lipid classes in sebum by rapid resolution high-performance liquid chromatography and electrospray mass spectrometry. |
2010 |
J. Lipid Res. |
pmid:20719760
|
Watanabe T et al. |
Novel pyrrole- and 1,2,3-triazole-based 2,3-oxidosqualene cyclase inhibitors. |
2010 |
Bioorg. Med. Chem. Lett. |
pmid:20728352
|
Ray R et al. |
Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins. |
2010 |
J. Infect. Dis. |
pmid:20677942
|
Nováková Z et al. |
Effects of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor pravastatin on membrane lipids and membrane associated functions of Methanothermobacter thermautotrophicus. |
2010 |
Folia Microbiol. (Praha) |
pmid:20680571
|
Bate J et al. |
Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. |
2010 |
Clin. Infect. Dis. |
pmid:21067352
|
Madhun AS et al. |
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. |
2010 |
Vaccine |
pmid:21034828
|
Kato S et al. |
Clinical evaluation of fullerene-C60 dissolved in squalane for anti-wrinkle cosmetics. |
2010 |
J Nanosci Nanotechnol |
pmid:21137794
|
Lin FY et al. |
Mechanism of action and inhibition of dehydrosqualene synthase. |
2010 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21098670
|
Ali NA et al. |
Essential oil composition of leaves of Stachys yemenensis obtained by supercritical COâ‚‚. |
2010 |
Nat. Prod. Res. |
pmid:21104527
|
Walker WT and Faust SN |
Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine. |
2010 |
Expert Rev Vaccines |
pmid:21105775
|
Beran J et al. |
A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses. |
2010 |
Clin Ther |
pmid:21316535
|
El Sahly H |
MF59™ as a vaccine adjuvant: a review of safety and immunogenicity. |
2010 |
Expert Rev Vaccines |
pmid:20923265
|
Waddington C et al. |
Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. |
2010 |
Health Technol Assess |
pmid:20923610
|
Montana M et al. |
Safety review: squalene and thimerosal in vaccines. |
2010 Nov-Dec |
Therapie |
pmid:21176760
|
Tsai TF |
MF59 adjuvanted seasonal and pandemic influenza vaccines. |
2011 |
Yakugaku Zasshi |
pmid:22129867
|
Puig-Barberà J et al. |
MF59â„¢-adjuvanted seasonal influenza vaccine in young children. |
2011 |
Expert Rev Vaccines |
pmid:22043952
|
Viganò A et al. |
Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial. |
2011 |
Clin. Vaccine Immunol. |
pmid:21795458
|
Huijskens E et al. |
Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population. |
2011 |
Clin. Vaccine Immunol. |
pmid:21795459
|
Launay O et al. |
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. |
2011 |
J. Infect. Dis. |
pmid:21628666
|
Piccialli V et al. |
Isolation of a bis-iodurated tetra-THF as a trace product from the oxidation of squalene with RuOâ‚„ and its double ring expansion to a novel bis-THF-bis-THP compound. |
2011 |
Molecules |
pmid:21709619
|
Esposito S et al. |
Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. |
2011 |
Pediatrics |
pmid:21464195
|
Esposito S et al. |
An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients. |
2011 |
Nephrol. Dial. Transplant. |
pmid:20974645
|